Calamos Advisors LLC Tandem Diabetes Care Inc Transaction History

Calamos Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$53.22 - $123.09 $1.08 Million - $2.5 Million	-20,349 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$101.89 - $150.09 $1.29 Million - $1.9 Million	12,688 Added 165.62%	20,349 $2.37 Million
Q4 2021 Feb 01, 2022	BUY	$118.18 - $153.21 $905,376 - $1.17 Million	7,661 New	7,661 $1.15 Million
Q4 2020 Jan 27, 2021	SELL	$86.4 - $121.75 $3.64 Million - $5.13 Million	-42,160 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$95.43 - $116.09 $609,129 - $741,002	6,383 Added 17.84%	42,160 $4.79 Million
Q2 2020 Jul 27, 2020	BUY	$60.05 - $98.92 $292,023 - $481,047	4,863 Added 15.73%	35,777 $3.54 Million
Q1 2020 Apr 28, 2020	BUY	$47.37 - $90.04 $1.46 Million - $2.78 Million	30,914 New	30,914 $1.99 Million
Q4 2019 Jan 15, 2020	SELL	$53.13 - $71.19 $5.65 Million - $7.57 Million	-106,390 Closed	0 $0
Q3 2019 Oct 21, 2019	SELL	$57.11 - $73.3 $1.71 Million - $2.2 Million	-29,957 Reduced 21.97%	106,390 $6.27 Million
Q2 2019 Aug 07, 2019	BUY	$54.41 - $71.7 $7.42 Million - $9.78 Million	136,347 New	136,347 $8.8 Million

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.98B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.